Enveric Biosciences Inc (ENVB) — Cash Flow-to-Debt Ratio
Enveric Biosciences Inc (ENVB) has a Cash Flow-to-Debt Ratio of -2.29x as of September 2025, meaning its operating cash flow of $-2.07 Million could theoretically repay -2% of its total liabilities ($905.88K) in one year. Check how aggressively does Enveric Biosciences Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Enveric Biosciences Inc Cash Flow-to-Debt Ratio (1994–2024)
Historical debt coverage capacity for Enveric Biosciences Inc across 31 annual periods. Also explore Enveric Biosciences Inc total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Enveric Biosciences Inc (1994–2024)
Year-by-year debt coverage analysis for Enveric Biosciences Inc. For market capitalisation and broader financial context, see ENVB market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -5.19x | $-7.73 Million | $1.49 Million | ▲ +13.8% |
| 2023 | -6.01x | $-14.09 Million | $2.34 Million | ▼ -40.2% |
| 2022 | -4.29x | $-17.15 Million | $4.00 Million | ▼ -65.3% |
| 2021 | -2.60x | $-11.46 Million | $4.41 Million | ▲ +54.5% |
| 2020 | -5.71x | $-3.89 Million | $681.25K | ▼ -12573.4% |
| 2019 | -0.05x | $-647.86K | $14.38 Million | ▲ +66.9% |
| 2018 | -0.14x | $-2.57 Million | $18.88 Million | ▼ -62.4% |
| 2017 | -0.08x | $-2.74 Million | $32.75 Million | ▲ +13.8% |
| 2016 | -0.10x | $-2.70 Million | $27.84 Million | ▲ +64.1% |
| 2015 | -0.27x | $-3.67 Million | $13.58 Million | ▲ +94.4% |
| 2014 | -4.82x | $-43.16K | $8.96K | ▼ -450.2% |
| 2013 | -0.88x | $-21.63K | $24.70K | ▲ +9.5% |
| 2012 | -0.97x | $-24.85K | $25.67K | ▲ +42.9% |
| 2011 | -1.70x | $-30.35K | $17.89K | ▼ -111.2% |
| 2010 | -0.80x | $-40.67K | $50.64K | ▲ +85.3% |
| 2009 | -5.48x | $-65.04K | $11.87K | ▲ +22.6% |
| 2008 | -7.08x | $-150.19K | $21.21K | ▼ -202.8% |
| 2007 | 6.89x | $329.93K | $47.90K | ▲ +296.0% |
| 2006 | -3.51x | $-305.91K | $87.08K | ▼ -145.8% |
| 2005 | -1.43x | $-256.57K | $179.52K | ▼ -376.9% |
| 2004 | 0.52x | $343.94K | $666.31K | ▲ +150.8% |
| 2003 | -1.02x | $-253.97K | $249.77K | ▼ -478.6% |
| 2002 | 0.27x | $85.14K | $317.01K | ▲ +127.0% |
| 2001 | -0.99x | $-339.68K | $341.54K | ▼ -649.9% |
| 2000 | 0.18x | $145.84K | $806.35K | ▲ +136.7% |
| 1999 | -0.49x | $-665.38K | $1.35 Million | ▲ +59.8% |
| 1998 | -1.22x | $-3.00 Million | $2.45 Million | ▲ +45.7% |
| 1997 | -2.25x | $-3.70 Million | $1.64 Million | ▲ +58.3% |
| 1996 | -5.41x | $-4.72 Million | $873.32K | ▼ -5.2% |
| 1995 | -5.14x | $-3.60 Million | $700.00K | ▼ -478.6% |
| 1994 | -0.89x | $-800.00K | $900.00K | — |